Form D · Other Health Care

Vicarious Surgical Inc.

Waltham, MA · CIK 0001812173

Offering snapshot reported Oct 15, 2025 · SEC filing

Reported sold
$11.7M
Offering amount: $11.7M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 9, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 15, 2025Initial$11,730,000No comparison1SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$352K
Finders' fees
$0
Form D file number
021-560942
The total offering amount reflects the total gross proceeds to be received assuming cash exercise of all warrants issued in the private placement.
The placement agent received a cash placement fee equal to 6.0% of the gross proceeds received from the sale of the securities sold in the registered direct offering and the concurrent private placement, plus expense reimbursement of $100,000.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Lake Street Capital Markets, LLC000164447

Source: Form D, filed Oct 15, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

Each card uses that adviser's latest imported filing. Filing dates can differ; these disclosures do not confirm a current relationship.

Matched by reported Form D file number

DES MSF HOLDINGS LLC

Investment adviser: GOLDMAN SACHS ASSET MANAGEMENT, L.P.

Gross asset value
$17.3M
Beneficial owners
3
ADV minimum commitment
$1M

Reported in Form ADV on Aug 21, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator SEI GLOBAL SERVICES, INC. OAKS, Pennsylvania, United States Investor statements: No (provided to no investors) Related to adviser: No Other funds reporting this name →
Auditor PRICEWATERHOUSECOOPERS LLP BOSTON, Massachusetts, United States Other funds reporting this name →
Custodian CITIBANK, NATIONAL ASSOCIATION NEW YORK, New York, United States Related to adviser: No Other funds reporting this name →
Marketer GOLDMAN SACHS & CO. LLC NEW YORK, New York, United States Related to adviser: Yes Other funds reporting this name →
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
Yes

PRICEWATERHOUSECOOPERS LLP
PCAOB 238

CITIBANK, NATIONAL ASSOCIATION
LEI E57ODZWZ7FF32TWEFA76

GOLDMAN SACHS & CO. LLC
CRD 361 · SEC 801-16048

Fund asset history · 1 annual observations Gross asset value by annual ADV filing$0$8.64M$17.3MFY 2025: $17,284,898.00FY 2025

Scroll to see all columns →

Fiscal yearGross assetsBeneficial ownersADV filed
2025$17,284,8983Mar 31, 2026
Filing source

Form ADV 2125383 · Aug 21, 2026 · Schedule D 7.B.(1), fund 805-7769004201

Reported by GOLDMAN SACHS ASSET MANAGEMENT, L.P. (CRD 107738).

Other-Than Anual Amendment For Registered Adviser.

Official IAPD profile (latest public filing). Historical values on this page come from the SEC/IAPD filing archive; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Fuad Ahmad Director
Victoria Carr Brendel Director
Randy Clark Director
Joseph Doherty Director
Stephen From Director, Executive
David Ho Director
Beverly Huss Director
Sammy Khalifa Director, Executive
Sarah Romano Executive
Adam Sachs Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
78 Fourth Avenue
Waltham, MA, 02451
Phone: (617) 868-1700